Overview

Oxytocin and Affect Processing in Posttraumatic Stress Disorder

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The investigators will use multiple methods (including Oxytocin intranasal inhalation, neuroimaging, behavioral measures, peripheral hormone measurements) to examine how individuals' behavior, cognition, and brain function is impacted by the neuro-hormone Oxytocin. Specifically, the investigators plan to evaluate the influence of Oxytocin administration on affective processing in non-trauma exposed and trauma-exposed adults (both with and without posttraumatic stress disorder, PTSD).
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Center for PTSD
Treatments:
Oxytocin